Graphite Bio Inc (GRPH) Actualités

Form 425 - Prospectuses and communications, business combinations

Form 8-K - Current report

Graphite Bio Declares Special Dividend In Connection with Proposed Merger with Lenz Therapeutics

Special dividend estimated to be $1.03 per share Payment of special dividend conditioned upon closing of merger Graphite Bio, Inc. (Nasdaq: GRPH...

Form 425 - Prospectuses and communications, business combinations

Form 8-K - Current report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form S-4/A - Registration of securities, business combinations: [Amend]

Form S-4/A - Registration of securities, business combinations: [Amend]

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Form 425 - Prospectuses and communications, business combinations

Form 8-K - Current report

Form S-4 - Registration of securities, business combinations

Form 425 - Prospectuses and communications, business combinations

Form 425 - Prospectuses and communications, business combinations